[Skip to Navigation]
January 1981

Facial Erysipelas in the Immunocompromised Host: Report of Two Cases

Author Affiliations

From the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Arch Dermatol. 1981;117(1):47-49. doi:10.1001/archderm.1981.01650010053026

• Two cases of facial erysipelas in immunologically altered hosts are reported herein. The unusual presentation with absence of erythema in the skin lesion is emphasized. Atypical fever patterns were also noted. In one patient, the facial lesion followed the onset of fever by 48 hours, and, in the other, the facial swelling preceded the fever. Various aspects of the patient's altered host status are discussed in light of the atypical clinical presentation. Recognition of facial erysipelas as a potential source of group A β-hemolytic streptococcemia in immunealtered hosts is important to ensure rapid and appropriate therapeutic intervention.

(Arch Dermatol 117:47-49, 1981)

Add or change institution